NRG Therapeutics Announces £16 million Series A to Advance Mitochondrial Therapeutics for Parkinson’s and ALS Read more
Royalty Pharma Agrees to Acquire Royalty Interest in Olpasiran from Arrowhead for $250 Million and Future Milestones Read more
Sun Pharma and SPARC enter into a license agreement for commercialization of phenobarbital for injection in the US Read more
Spero Therapeutics Announces Closing of Exclusive License Agreement with GSK for Tebipenem HBr Read more
Salipro Biotech enters into collaboration and license agreement with Sanofi to advance discovery programs Read more
Navrogen Enters into CRADA with The U.S. National Cancer Institute for the Clinical Development of NAV-001, an Anti-Mesothelin Antibody-Drug Conjugate Read more